Predicting onset of Alzheimer disease symptoms with a plasma %p‐tau217 clock

AAIC 2025 Abstract

Abstract

Background: Time proxies based on blood biomarkers may facilitate understanding of the timing of biomarker change and symptom onset in Alzheimer's disease (AD) and could potentially enable biological staging of AD.

The paper